However, it is known that the CD4+ and CD25+ markers contain populations of Tregs and effector T-cells 6 and Foxp3+ is not restricted to Tregs and may be also activated in other cell types, such as effector T-cells and tumor cells.28 Here, FOXP3 is linked to neoplasm.